DS
BMY icon

Dudley & Shanley’s Bristol-Myers Squibb BMY Stock Holding History

Dudley & Shanley’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-251,196
Closed -$19.3M – 30
2022
Q2 		$19.3M Sell
251,196
-5,175
-2% -$394K 4.33% 13
2022
Q1 		$18.7M Buy
256,371
+160,130
+166% +$10.8M 3.48% 16
2021
Q4 		$6M Sell
96,241
-476,769
-83% -$28M 1.04% 22
2021
Q3 		$33.9M Sell
573,010
-21,990
-4% -$1.45M 5.96% 4
2021
Q2 		$39.8M Buy
595,000
+1,450
+0.2% +$94.5K 6.56% 2
2021
Q1 		$37.5M Sell
593,550
-6,340
-1% -$394K 6.47% 3
2020
Q4 		$37.2M Buy
599,890
+133,200
+29% +$8.19M 6.85% 2
2020
Q3 		$28.1M Buy
466,690
+83,100
+22% +$5M 6.83% 5
2020
Q2 		$22.6M Sell
383,590
-96,400
-20% -$5.77M 6.24% 9
2020
Q1 		$26.8M Buy
479,990
+157,115
+49% +$9.6M 6.72% 3
2019
Q4 		$20.7M Buy
+322,875
New +$18.5M 4.67% 12

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dudley & Shanley's BMY Position: Q3 2022 in Review

Dudley & Shanley sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 251,196 shares — an estimated $19.3M sold.

Dudley & Shanley first reported a position in BMY in Q4 2019 and held it in 11 quarters. The position peaked at $39.8M in Q2 2021. 2,472 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

  • Dudley & Shanley reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
  • Dudley & Shanley sold 251,196 Bristol-Myers Squibb shares in Q3 2022, an estimated $19.3M.
  • Dudley & Shanley first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 11 quarters.
  • Dudley & Shanley's Bristol-Myers Squibb position peaked at $39.8M in Q2 2021.
  • 2,472 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Dudley & Shanley's 13F filing for Q3 2022, filed 18 Oct 2022.